Back
ESC Professional Premium Access

Investigation of biomarker response to SGLT2 Inhibition in heart failure (SiN-HF)

Session: New perspectives in cardiology (2) - Diagnosis and biomarkers of heart failure
Topic: Biomarkers
Speaker: Doctor P. Savage (Belfast, GB)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Patrick Savage

Belfast Health and Social Care Trust, Belfast (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Discussant - Diagnosis and biomarkers of heart failure

Access
Like
Thumbnail

Human epididymis protein 4 contributes to lower systolic function and poor prognosis in heart failure with reduced ejection fraction.

Speaker: Doctor Y. Okuno (Kumamoto, JP)

Access
Abstract
Like
Thumbnail

The role of C-reactive protein-albumin and red blood cell distribution width to albumin level ratio change in patients with heart failure in the SGLT2 era

Speaker: Doctor M. Vidak (Zagreb, HR)

Access
Abstract
Slides
Video
Like
Thumbnail

Discovery of miRNAs unique to actively transcribed erythroparvovirus infection in heart failure patients

Speaker: Doctor G. Aleshcheva (Berlin, DE)

Access
Abstract
Slides
Like
Thumbnail

Baseline serum sodium as a non-negligible factor predicting increased risk of 3-month mortality in patients with light-chain amyloidosis diagnosed in cardiology department

Speaker: Mr J. Malinowski (Warsaw, PL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

New perspectives in cardiology (2) - Diagnosis and biomarkers of heart failure

Speakers: Doctor P. Savage, Doctor Y. Okuno, Doctor M. Vidak, Doctor G. Aleshcheva, Mr J. Malinowski
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources